217 related articles for article (PubMed ID: 28418879)
1. Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer.
Meng Q; Xiang L; Fu J; Chu X; Wang C; Yan B
Oncotarget; 2017 Jun; 8(23):37321-37331. PubMed ID: 28418879
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2.
Wang F; Liu J; Zou Y; Jiao Y; Huang Y; Fan L; Li X; Yu H; He C; Wei W; Wang H; Sun G
Oncotarget; 2017 Apr; 8(17):28711-28724. PubMed ID: 28404925
[TBL] [Abstract][Full Text] [Related]
4. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
5. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.
Kong P; Zhu X; Geng Q; Xia L; Sun X; Chen Y; Li W; Zhou Z; Zhan Y; Xu D
Mol Ther; 2017 Apr; 25(4):1027-1037. PubMed ID: 28254439
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
8. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
10. microRNA analysis of gastric cancer patients from Saudi Arabian population.
Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1.
Shen X; Si Y; Yang Z; Wang Q; Yuan J; Zhang X
Med Oncol; 2015 Jan; 32(1):361. PubMed ID: 25432696
[TBL] [Abstract][Full Text] [Related]
12. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
13. miR-24-3p Regulates Progression of Gastric Mucosal Lesions and Suppresses Proliferation and Invasiveness of N87 Via Peroxiredoxin 6.
Li Q; Wang N; Wei H; Li C; Wu J; Yang G
Dig Dis Sci; 2016 Dec; 61(12):3486-3497. PubMed ID: 27743162
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
Eun JW; Kim HS; Shen Q; Yang HD; Kim SY; Yoon JH; Park WS; Lee JY; Nam SW
J Pathol; 2018 Jan; 244(1):107-119. PubMed ID: 28991363
[TBL] [Abstract][Full Text] [Related]
15. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
[TBL] [Abstract][Full Text] [Related]
18. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer.
Wang Z; Wang J; Yang Y; Hao B; Wang R; Li Y; Wu Q
J Exp Clin Cancer Res; 2013 Oct; 32(1):76. PubMed ID: 24422944
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer.
Yuan H; Chen Z; Bai S; Wei H; Wang Y; Ji R; Guo Q; Li Q; Ye Y; Wu J; Zhou Y; Qiao L
Cancer Lett; 2018 Apr; 418():84-96. PubMed ID: 29337109
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibitory effects of three miR-129 family members on gastric cancer.
Yu X; Song H; Xia T; Han S; Xiao B; Luo L; Xi Y; Guo J
Gene; 2013 Dec; 532(1):87-93. PubMed ID: 24055727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
